Radiotherapy for a rising PSA following radical prostatectomy

Urologic Oncology: Seminars and Original Investigations

Volumn 22, Issue 1, 2004, Pages 57-61

  Macdonald, O Kenneth ^a   Schild, Steven E ^a  

^a MAYO CLINIC   (United States)

Author keywords

Prostate cancer; Prostate specific antigen; Prostatectomy; Salvage radiation therapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CONFERENCE PAPER; HUMAN; INCONTINENCE; PATIENT REFERRAL; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; RADIATION INJURY; SALVAGE THERAPY; TREATMENT OUTCOME; UROGENITAL TRACT DISEASE;

HUMANS; MALE; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RECURRENCE; SALVAGE THERAPY;

EID: 2142642211     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2003.12.004     Document Type: Conference Paper

References (31)

1. Jemal A., Murray T., Samuels A., et al. Cancer Statistics, 2003. CA Cancer J Clin. 53:2003;5-26
2. Stephenson R.A., Stanford J.L. Population-based prostate cancer trends in the United States patterns of change in the era of prostate-specific antigen. World J Urol. 15:1997;331-335
3. Pound C.R., Partin A.W., Eisenberger M.A., et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 281:1999;1591-1597
4. Ornstein D.K., Colberg J.W., Virgo K.S., et al. Evaluation and management of men whose radical prostatectomies failed results of an international survey. Urology. 52:1998;1047-1054
5. Macdonald O.K., Schild S.E., Vora S.A., et al. Radiotherapy for men with isolated increase of serum prostate specific antigen after prostatectomy. J Urol. 170:2003;1833-1837
6. Schild S.E., Buskirk S.J., Wong W.W., et al. The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy. J Urol. 156:1996;1725-1729
7. Pisansky T.M., Kozelsky T.F., Myers R.P., et al. Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer. J Urol. 163:2000;845-850
8. Chawla A.K., Thakral H.K., Zietman A.L., et al. Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma analysis of efficacy and prognostic factors. Urology. 59:2002;726-731
9. Cadeddu J.A., Partin A.W., DeWeese T.L., et al. Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy. J Urol. 159:1998;173-177
10. Macdonald OK, Schild SE, Vora SA, et al. Salvage radiotherapy for palpable, locally recurrent prostate cancer after prostatectomy. Int J Radiat Oncol Biol Phys (in press)
11. Choo R., Hruby G., Hong J., et al. (IN)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy. Int J Radiat Oncol Biol Phys. 53:2002;269-276
12. Crane C.H., Rich T.A., Read P.W., et al. Preirradiation PSA predicts biochemical disease-free survival in patients treated with postprostatectomy external beam irradiation. Int J Radiat Oncol Biol Phys. 39:1997;681-686
13. Forman J.D., Velasco J. Therapeutic radiation in patients with a rising post-prostatectomy PSA level. Oncology (Huntingt). 12:1998;33-39
14. Do T., Parker R.G., Do C., et al. Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy. Cancer J Sci Am. 4:1998;324-330
15. Cox J.D., Gallagher M.J., Hammond E.H., et al. Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Consensus Panel. J Clin Oncol. 17:1999;1155-1163
16. Song D.Y., Thompson T.L., Ramakrishnan V., et al. Salvage radiotherapy for rising or persistent PSA after radical prostatectomy. Urology. 60:2002;281-287
17. Anscher M.S., Clough R., Dodge R. Radiotherapy for a rising prostate-specific antigen after radical prostatectomy the first 10 years. Int J Radiat Oncol Biol Phys. 48:2000;369-375
18. Katz M.S., Zelefsky M.J., Venkatraman E.S., et al. Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer. J Clin Oncol. 21:2003;483-489
19. Parker C.C., Dearnaley D.P. The management of PSA failure after radical radiotherapy for localized prostate cancer. Radiother Oncol. 49:1998;103-110
20. Egawa S., Ohori M., Iwamura M., et al. Efficacy and limitations of delayed/salvage radiation therapy after radical prostatectomy. BJU Int. 84:1999;815-820
21. Leventis A.K., Shariat S.F., Kattan M.W., et al. Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy. J Clin Oncol. 19:2001;1030-1039
22. Catton C., Gospodarowicz M., Warde P., et al. Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate. Radiother Oncol. 59:2001;51-60
23. Bolla M., Collette L., Blank L., et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study) a phase III randomised trial. Lancet. 360:2002;103-108
24. Pilepich M.V., Winter K., John M.J., et al. Phase III Radiation Therapy Oncology Group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 50:2001;1243-1252
25. Lawton C.A., Winter K., Murray K., et al. Updated Results of the Phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 49:2001;937-946
26. Taylor N., Kelly J.F., Kuban D.A., et al. Adjuvant and salvage radiotherapy after radical prostatecomy for prostate cancer. Int J Radiat Oncol Biol Phys. 56:2003;755-763
27. Garg M.K., Tekyi-Mensah S., Bolton S., et al. Impact of postprostatectomy prostate-specific antigen nadir on outcomes following salvage radiotherapy. Urology. 51:1998;998-1002
28. Syndikus I., Pickles T., Kostashuk E., et al. Postoperative radiotherapy for stage pT3 carcinoma of the prostate improved local control. J Urol. 155:1996;1983-1986
29. Koppie T.M., Grossfeld G.D., Nudell D.M., et al. Is anastomotic biopsy necessary before radiotherapy after radical prostatectomy? J Urol. 166:2001;111-115
30. Rogers R., Grossfeld G.D., Roach M. 3rd, et al. Radiation therapy for the management of biopsy proved local recurrence after radical prostatectomy. J Urol. 160:1998;1748-1753
31. vander Kooy M.J., Pisansky T.M., Cha S.S., et al. Irradiation for locally recurrent carcinoma of the prostate following radical prostatectomy. Urology. 49:1997;65-70